PDQ-39 used to evaluate Health-Related Quality of Life in randomized controlled trial that uses DBS system to treat patients with Parkinson’s disease
Patients were implanted bilaterally with Boston Scientific’s FDA-approved Vercise Genus DBS system. During long-term follow-up, quality of life was evaluated using the Parkinson’s Disease Questionnaire (PDQ-39).